Literature DB >> 21310477

The adenylate cyclase toxin of Bacillus anthracis is a potent promoter of T(H)17 cell development.

Silvia Rossi Paccani, Marisa Benagiano, Maria Teresa Savino, Francesca Finetti, Fiorella Tonello, Mario M D'Elios, Cosima T Baldari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21310477     DOI： 10.1016/j.jaci.2010.12.1104

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  13 in total

Review 1.  Advances in basic and clinical immunology in 2011.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

2.  Group 3 innate lymphocytes (ILC3s) upregulate IL-22 in response to elevated intracellular cAMP levels.

Authors:  Prakash Sah; Jonathan T Derouen; Justine L Alexander; Lauren A Zenewicz
Journal:  Cytokine       Date:  2022-03-17       Impact factor: 3.926

3.  The IL-23/Th17 axis is involved in the adaptive immune response to Bacillus anthracis in humans.

Authors:  Kristina M Harris; Girish Ramachandran; Subhendu Basu; Sandra Rollins; Dean Mann; Alan S Cross
Journal:  Eur J Immunol       Date:  2014-01-02       Impact factor: 5.532

Review 4.  Anthrax lethal toxin and the induction of CD4 T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Daniel M Altmann
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

5.  The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapse.

Authors:  Silvia Rossi Paccani; Francesca Finetti; Marilyne Davi; Laura Patrussi; Mario M D'Elios; Daniel Ladant; Cosima T Baldari
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

Review 6.  T cell targeting by anthrax toxins: two faces of the same coin.

Authors:  Silvia Rossi Paccani; Cosima T Baldari
Journal:  Toxins (Basel)       Date:  2011-06-20       Impact factor: 4.546

7.  Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines.

Authors:  Rebecca J Ingram; Stephanie Ascough; Catherine J Reynolds; Gökhan Metan; Mehmet Doganay; Les Baillie; Diane E Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  Cell Biosci       Date:  2015-04-26       Impact factor: 7.133

8.  Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Karen K Chu; Catherine J Reynolds; Julie A Musson; Mehmet Doganay; Gökhan Metan; Yusuf Ozkul; Les Baillie; Shiranee Sriskandan; Stephen J Moore; Theresa B Gallagher; Hugh Dyson; E Diane Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

Review 9.  Cellular and physiological effects of anthrax exotoxin and its relevance to disease.

Authors:  David E Lowe; Ian J Glomski
Journal:  Front Cell Infect Microbiol       Date:  2012-06-01       Impact factor: 5.293

10.  Colonic immune suppression, barrier dysfunction, and dysbiosis by gastrointestinal bacillus anthracis Infection.

Authors:  Yaíma L Lightfoot; Tao Yang; Bikash Sahay; Mojgan Zadeh; Sam X Cheng; Gary P Wang; Jennifer L Owen; Mansour Mohamadzadeh
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.